Sort
48,018 grants matching “immunotherapy”
SPORE in Breast Cancer
$2,031,380Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2022 · CA
Seattle Cancer Consortium Breast SPORE
$2,031,363Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2013 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$2,031,035Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2002 · AI
Head and Neck Cancer SPORE
$2,030,091Robert L Ferris · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA
Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS
$2,029,401Jay A Berzofsky · Clinical Sciences · Z01 · FY2007 · CA
Developmental Therapeutics Program
$2,029,064James V Degregori · University Of Colorado Denver · P30 · FY2025 · CA
Identifying Metabolic Vulnerabilities in Lung Cancer
$2,029,016Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2022 · CA
UNIVERSITY OF TEXAS MD ANDERSON SPORE IN OVARIAN CANCER
$2,028,681University Of Texas Md Anderson Can Ctr · P50 · FY2001 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$2,028,458Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2003 · AI
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$2,028,388Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Human T-Cell Responses to Tumor Antigens
$2,027,509Jeffrey Schlom · Basic Sciences · Z01 · FY2007 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$2,025,978Ohio State University · U01 · FY2003 · AI
Center for Immunotherapies to Zoonotic Diseases
$2,025,789Allen G Harmsen · Montana State University - Bozeman · P20 · FY2006 · RR
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
$2,024,997Luc Teyton · Scripps Research Institute, The · P01 · FY2023 · AI
Center for Applied Immunology and Pathological Processes
$2,024,418Andrew D Yurochko · Louisiana State Univ Hsc Shreveport · P20 · FY2025 · GM
Hematopoietic Chimerism after Stem Cell Allografts
$2,023,730Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2017 · CA
Hematopoietic Chimerism after Stem Cell Allografts
$2,023,730Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2016 · CA
Pancreatic Cancer Development: Genetic and Immune Regulation
$2,023,000Seung K Kim · Stanford University · P01 · FY2025 · CA
Mechanisms Underlying Clearance of Persistent Infections
$2,022,862Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Host-Tumor Cell Interactions in Myeloma:
$2,021,516Dana-Farber Cancer Institute · P01 · FY2005 · CA
Mixed Hematopoietic Chimerism after Stem Cell Allografts
$2,019,270Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2006 · CA
Identifying Metabolic Vulnerabilities in Lung Cancer
$2,019,244Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2023 · CA
Hematopoietic Chimerism after Stem Cell Allografts
$2,019,079Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA
Immunotherapy for Malignant Mesothelioma and Lung Cancer
$2,018,756Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Immune modulating therapies to treat complex regional pain syndrome
$2,018,200Seena Ajit · Drexel University · RF1 · FY2022 · NS